160
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Morin supplementation modulates PERK branch of UPR and mitigates 1,2-dimethylhydrazine-induced angiogenesis and oxidative stress in the colon of experimental rats

, , &
Pages 306-315 | Received 05 Sep 2019, Accepted 05 Feb 2020, Published online: 20 Feb 2020

References

  • Bellezza I, Giambanco I, Minelli A, Donato R. 2018. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim Biophys Acta Mol Cell Res. 1865(5):721–733.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:94–424.
  • Chan K, Kan YW. 1999. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA. 96(22):12731–12736.
  • Cullinan SB, Diehl JA. 2006. Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. Int J Biochem Cell Biol. 38(3):317–332.
  • Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA. 2003. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol. 23(20):7198–7209.
  • Danzi M, Lewin MR, Cruse JP, Clark CG. 1983. Combination chemotherapy with 5-fluorouracil (5FU) and 1,3-bis(2-chloro-ethyl)-1-nitrosourea (BCNU) prolongs survival of rats with dimethylhydrazine-induced colon cancer. Gut. 24(11):1041–1047.
  • Deng Y. 2017. Rectal cancer in Asian vs. Western countries: why the variation in incidence? Curr Treat Options Oncol. 18(10):64.
  • Eletto D, Chevet E, Argon Y, Appenzeller-Herzog C. 2014. Redox controls UPR to control redox. J Cell Sci. 127(17):3649–3658.
  • Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell. 144(5):646–674.
  • Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, Ron D. 2000. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell. 6(5):1099–1108.
  • Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun C, Popko B, Paules R, et al. 2003. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell. 11(3):619–633.
  • Harrison IP, Selemidis S. 2014. Understanding the biology of reactive oxygen species and their link to cancer: NADPH oxidases as novel pharmacological targets. Clin Exp Pharmacol Physiol. 41(8):533–542.
  • Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, et al. 1997. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 236(2):313–322.
  • Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel J. D, Yamamoto M. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13(1):76–86.
  • Karthik Kumar V, Vennila S, Nalini N. 2009. Modifying effects of morin on the development of aberrant crypt foci and bacterial enzymes in experimental colon cancer. Food Chem Toxicol. 47(2):309–315.
  • Karthik Kumar V, Vennila S, Nalini N. 2010. Inhibitory effect of morin on DMH-induced biochemical changes and aberrant crypt foci formation in experimental colon carcinogenesis. Environ Toxicol Pharmacol. 29(1):50–57.
  • Kim I, Xu W, Reed JC. 2008. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov. 7(12):1013–1030.
  • Li J, Lee AS. 2006. Stress induction of GRP78/BiP and its role in cancer. CMM. 6(1):45–54.
  • Loinard C, Zouggari Y, Rueda P, Ramkhelawon B, Cochain C, Vilar J, Ré Calde A, Richart A, Charue D, Duriez M, et al. 2012. C/EBP homologous protein-10 (CHOP-10) limits postnatal neovascularization through control of endothelial nitric oxide synthase gene expression. Circulation. 125(8):1014–1026.
  • Ma Y, Hendershot LM. 2004. The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer. 4(12):966–977.
  • Mahadevan NR, Zanetti M. 2011. Tumor stress inside out: cell-extrinsic effects of the unfolded protein response in tumor cells modulate the immunological landscape of the tumor microenvironment. J Immunol. 187(9):4403–4409.
  • Nishida N, Yano H, Nishida T, Kamura T, Kojiro M. 2006. Angiogenesis in cancer. Vasc Health Risk Manag. 2(3):213–219.
  • Nishitoh H. 2012. CHOP is a multifunctional transcription factor in the ER stress response. J Biochem. 151(3):217–219.
  • Petzer JP, Navamal M, Johnson JK, Kwak MK, Kensler TW, Fishbein JC. 2003. Phase 2 enzyme induction by the major metabolite of oltipraz. Chem Res Toxicol. 16(11):1463–1469.
  • Sessa WC. 2004. eNOS at a glance. J Cell Sci. 117(12):2427–2429.
  • Sharma D, Singh G. 2017. Clinico-pathological profile of colorectal cancer in first two decades of life: A retrospective analysis from tertiary health center. Indian J Cancer. 54(2):397.
  • Sharma SH, Kumar JS, Chellappan DR, Nagarajan S. 2018a. Molecular chemoprevention by morin - a plant flavonoid that targets nuclear factor kappa B in experimental colon cancer. Biomed Pharmacother. 100:367–373.
  • Sharma SH, Rajamanickam V, Nagarajan S. 2018b. Antiproliferative effect of p-Coumaric acid targets UPR activation by downregulating Grp78 in colon cancer. Chem Biol Interact. 291:16–28.
  • Sharma SH, Thulasingam S, Chellappan DR, Chinnaswamy P, Nagarajan S. 2017. Morin and Esculetin supplementation modulates c-myc induced energy metabolism and attenuates neoplastic changes in rats challenged with the procarcinogen 1,2 - dimethylhydrazine. Eur J Pharmacol. 796:20–31.
  • Shibuya M. 2011. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer. 2:1097–1105.
  • Urra H, Dufey E, Lisbona F, Rojas-Rivera D, Hetz C. 2013. When ER stress reaches a dead end. Biochim Biophys Acta. 1833(12):3507–3517.
  • Ushio-Fukai M, Nakamura Y. 2008. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 266(1):37–52.
  • Walter P, Ron D. 2011. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 25:1081–1086.
  • Wang Y, Alam GN, Ning Y, Visioli F, Dong Z, Nör JE, Polverini PJ. 2012. The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK/ATF4 pathway. Cancer Res. 72(20):5396–5406.
  • Yamaguchi H, Wang HG. 2004. CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J Biol Chem. 279(44):45495–45502.
  • Zhang LH, Zhang X. 2010. Roles of GRP78 in physiology and cancer. J Cell Biochem. 110(6):1299–1305.
  • Zhao Y, Adjei AA. 2015. Targeting angiogenesis in cancer therapy: moving beyond vascular endothelial growth factor. Oncologist. 20(6):660–673.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.